×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ANTX – an2 therapeutics, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ANTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/12
07:00 am
antx
AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease
High
Report
AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease
11/12
04:27 pm
antx
AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
Medium
Report
AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
11/12
04:01 pm
antx
AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights
Medium
Report
AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights
11/10
07:11 am
antx
AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB) [Yahoo! Finance]
Medium
Report
AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB) [Yahoo! Finance]
11/10
07:00 am
antx
AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB)
Medium
Report
AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB)
11/6
05:03 pm
antx
AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference
Low
Report
AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/7
08:15 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Prior Stephen David
High
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Prior Stephen David
1/7
08:15 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Day Lucy
High
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Day Lucy
1/7
08:13 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Chanda Sanjay
High
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Chanda Sanjay
1/7
08:12 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Eizen Joshua M
High
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Eizen Joshua M
11/14
07:51 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Almitas Capital LLC
Low
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Almitas Capital LLC
11/12
04:21 pm
antx
Form 10-Q AN2 Therapeutics, Inc. For: Sep 30
Medium
Report
Form 10-Q AN2 Therapeutics, Inc. For: Sep 30
11/12
04:20 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Nov 12
Medium
Report
Form 8-K AN2 Therapeutics, Inc. For: Nov 12
11/6
06:12 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Eizen Joshua M
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Eizen Joshua M
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: